Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
INNOSPEC INC. (IOSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS All businesses contributed to revenue and operating income growth Continued strength in Fuel Specialties; Double-digit operating income growth in Performance Chemicals and Oilfield Services Cash flow of $17.4 million generated
How this was made
The 30-second read
Why it matters
Earnings beat, margin expansion, and dividend hike provide a fresh catalyst for price movement.
Market read
The earnings release offers new material that can drive short‑term trading decisions on IOSP.
What to watch
Higher raw material costs and Middle East operational delays could pressure future quarters.
All businesses contributed to revenue and operating income growth; GAAP EPS $1.29 and adjusted non-GAAP EPS $1.29.
Third-quarter revenue increased 7 percent, all three operating businesses reported higher revenue and operating income, and adjusted EBITDA rose to $51.4 million. Cash from operations declined from the prior-year quarter, while cash and cash equivalents were $251.9 million with no debt.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Net sales, three months ended September 30, 2026GAAP | $473.6M | – | 7 percent |
| Cost of goods sold, three months ended September 30, 2026GAAP | −$344.5M | – | – |
| Gross profit, three months ended September 30, 2026GAAP | $129.1M | – | – |
| Selling, general and administrative expense, three months ended September 30, 2026GAAP | −$71.7M | – | – |
| Research and development expense, three months ended September 30, 2026GAAP | −$16.8M | – | – |
| Total operating expenses, three months ended September 30, 2026GAAP | −$87.4M | – | – |
| Operating income, three months ended September 30, 2026GAAP | $41.7M | – | – |
| Other income/(expense), net, three months ended September 30, 2026GAAP | $500K | – | – |
| Interest income, net, three months ended September 30, 2026GAAP | $400K | – | – |
| Income before income taxes, three months ended September 30, 2026GAAP | $42.6M | – | – |
| Income taxes, three months ended September 30, 2026GAAP | −$11M | – | – |
| Net income, three months ended September 30, 2026GAAP | $31.6M | – | – |
| Net income attributable to Innospec, three months ended September 30, 2026GAAP | $31.8M | – | – |
| Basic earnings per share, three months ended September 30, 2026GAAP | $ 1.29 | – | – |
| Diluted earnings per share, three months ended September 30, 2026GAAP | $ 1.29 | – | – |
| Adjusted non-GAAP diluted EPS, three months ended September 30, 2026non-GAAP | $ 1.29 per diluted share | – | – |
| Adjusted EBITDA, three months ended September 30, 2026non-GAAP | $51.4M | – | – |
| Adjusted effective tax rate, three months ended September 30, 2026non-GAAP | 24.7 percent | – | – |
| Cash provided by operating activities, three months ended September 30, 2026GAAP | $17.4M | – | – |
| Capital expenditures, three months ended September 30, 2026other | $15.6M | – | – |
| Net sales, nine months ended September 30, 2026GAAP | $1.42B | – | – |
| Gross profit, nine months ended September 30, 2026GAAP | $390.9M | – | – |
| Operating income, nine months ended September 30, 2026GAAP | $117.9M | – | – |
| Net income attributable to Innospec, nine months ended September 30, 2026GAAP | $93M | – | – |
| Diluted earnings per share, nine months ended September 30, 2026GAAP | $ 3.75 | – | – |
| Adjusted EBITDA, nine months ended September 30, 2026non-GAAP | $145.2M | – | – |
| Cash provided by operating activities, nine months ended September 30, 2026GAAP | $42.2M | – | – |
| Capital expenditures, nine months ended September 30, 2026GAAP | −$42.4M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Performance ChemicalsVolume reductions of 5 percent and a negative currency impact of 1 percent were offset by a positive price and product mix of 12 percent. Gross margins were 18.8 percent, an increase of 3.7 percentage points, and operating income was $16.9 million, up 84 percent from $9.2 million. | $180.5M | – | 6 percent |
| Fuel SpecialtiesVolumes were up 3 percent and price and product mix was up 2 percent. Gross margins were 35.1 percent, down 0.5 percentage points, and operating income was $35.6 million, up 1 percent from $35.3 million. | $180.7M | – | 5 percent |
| Oilfield ServicesGross margins were 28.2 percent, down 1.8 percentage points on a weaker sales mix. Operating income was $6.7 million, up 40 percent from $4.8 million, driven by the recent DRA plant expansion. | $112.4M | – | 13 percent |
Capital returns
- Semi-annual dividend of 94 cents per common share for the second half of 2026, payable on November 25, 2026 to shareholders of record as of November 17, 2026.
- Annual dividend of $1.86 per share, a 9 percent increase over 2025.
- Dividend paid of $ (22.7) million in the nine months ended September 30, 2026, compared with $ (20.8) million in the prior-year period.
- Repurchase of common stock of $ (13.5) million in the nine months ended September 30, 2026, compared with $ (23.9) million in the prior-year period.
What drove it
- Performance Chemicals operating income increased 84 percent to $16.9 million, with sales growth and margin improvement cited as the drivers.
- Fuel Specialties delivered 5 percent revenue growth, supported by 3 percent volume growth and 2 percent price and product mix growth.
- Oilfield Services operating income increased 40 percent to $6.7 million, driven by the recent DRA plant expansion.
- The company expects to commission North Carolina plant efficiency upgrades by year-end, which are expected to increase capacity, productivity and yields.
- Third-quarter results included a $ 1.1 million adjustment to fair value of contingent consideration, $ 0.8 million of amortization of acquired intangible assets, $ 0.7 million of legacy costs of closed operations and $ (0.4) million of foreign currency exchange gains in the adjusted EPS reconciliation.
Concerns
- Third-quarter cash provided by operating activities was $17.4 million, compared with $39.1 million a year ago.
- Nine-month cash provided by operating activities was $ 42.2 million, compared with $ 77.9 million a year ago, while changes in working capital were $ (87.4) million.
- Fuel Specialties gross margins decreased by 0.5 percentage points to 35.1 percent.
- Oilfield Services gross margins decreased by 1.8 percentage points to 28.2 percent on a weaker sales mix.
- Oilfield Services sequential results were lower than expected due to continued activity delays in the legacy Middle East business and elevated raw material costs.
- Performance Chemicals volumes declined 5 percent and foreign currency had a negative 1 percent impact.
What to watch
- Commissioning of North Carolina plant efficiency upgrades by year-end and subsequent utilization of the new capacity.
- Whether Performance Chemicals sustains further growth and margin improvement as new-product progress continues.
- Expected sequential operating income growth in Oilfield Services in the fourth quarter.
- Working-capital efficiency and the company's stated focus on increasing operating cash flow in coming quarters.
- Fuel Specialties margins remaining within the company's target range.
Balance sheet and cash flow
- Cash and cash equivalents were $ 251.9 million as of September 30, 2026, compared with $ 292.5 million as of December 31, 2025.
- The company had no debt as of September 30, 2026; net cash was $251.9 million.
- Trade and other accounts receivable were $ 395.6 million as of September 30, 2026, compared with $ 342.3 million as of December 31, 2025.
- Inventories were $ 361.8 million as of September 30, 2026, compared with $ 329.3 million as of December 31, 2025.
- Total assets were $ 1,856.6 million as of September 30, 2026, compared with $ 1,832.4 million as of December 31, 2025.
- Equity was $ 1,380.3 million as of September 30, 2026, compared with $ 1,332.9 million as of December 31, 2025.
- Nine-month changes in working capital were $ (87.4) million, compared with $ (24.4) million in the prior-year period.
- Net cash used in investing activities was $ (45.8) million in the nine months ended September 30, 2026, compared with $ (55.9) million in the prior-year period.
- Net cash used in financing activities was $ (36.0) million in the nine months ended September 30, 2026, compared with $ (44.3) million in the prior-year period.
- Net change in cash and cash equivalents was $ (40.6) million in the nine months ended September 30, 2026, compared with $ (18.4) million in the prior-year period.
Analysis
Innospec reported third-quarter net sales of $473.6 million, up 7 percent from $441.9 million, with revenue growth across Performance Chemicals, Fuel Specialties and Oilfield Services. GAAP net income attributable to Innospec rose to $31.8 million from $12.9 million, while diluted GAAP EPS was $1.29 versus $0.52. The prior-year quarter included impairment charges and other special items, and adjusted non-GAAP EPS increased to $1.29 from $1.12. Adjusted EBITDA increased to $51.4 million from $44.2 million.
Performance Chemicals was the principal operating-income growth contributor. Revenue increased 6 percent to $180.5 million despite a 5 percent volume reduction and a negative 1 percent currency impact, as positive price and product mix of 12 percent more than offset those pressures. Its gross margin increased 3.7 percentage points to 18.8 percent and operating income increased 84 percent to $16.9 million. Fuel Specialties posted $180.7 million of revenue, up 5 percent, with 3 percent volume growth and 2 percent price and product mix growth. Its operating income increased 1 percent to $35.6 million, although gross margin declined 0.5 percentage points to 35.1 percent.
Oilfield Services generated the fastest segment revenue growth, with sales up 13 percent to $112.4 million and operating income up 40 percent to $6.7 million, supported by the recent DRA plant expansion. However, gross margin fell 1.8 percentage points to 28.2 percent on weaker sales mix. Management also identified continued activity delays in its legacy Middle East business and elevated raw-material costs as factors behind sequential results that were lower than expected. It expects improvement in several of those areas to support sequential operating-income growth in the fourth quarter.
Cash conversion was the principal weaker element of the release. Cash provided by operating activities was $17.4 million in the third quarter versus $39.1 million a year earlier. For the nine-month period, operating cash flow was $42.2 million versus $77.9 million, while changes in working capital were $ (87.4) million versus $ (24.4) million. Cash and cash equivalents were $251.9 million, with no debt. The company increased its semi-annual dividend to 94 cents per share, stated that annual dividend per share was $1.86, and repurchased $ (13.5) million of common stock in the first nine months.
Management did not provide formal numerical financial guidance. Its operational outlook centers on commissioning North Carolina plant-efficiency upgrades by year-end, improving utilization and new-product progress in Performance Chemicals, and expected fourth-quarter sequential operating-income growth in Oilfield Services. Management also highlighted better working-capital efficiency as its focus for increasing operating cash flow in coming quarters.
Management, verbatim
This was another good quarter for Innospec with all businesses contributing to solid revenue and strong operating income growth.
Patrick S. Williams, President and Chief Executive Officer
While sequential results were lower than expected on continued activity delays in our legacy Middle East business and elevated raw material costs, we are expecting improvement across several of these areas to drive sequential operating income growth in the fourth quarter.
Patrick S. Williams, President and Chief Executive Officer
We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency.
Patrick S. Williams, President and Chief Executive Officer
Not in the filing
stated, not guessed- Formal numerical forward revenue guidance
- Formal numerical forward gross-margin guidance
- Formal numerical forward operating-expense guidance
- Formal numerical forward tax-rate guidance
- Prior-period outlook for comparison
- Quarterly free cash flow
- Consolidated gross margin
- Prior-quarter comparisons for reported income-statement metrics
- Quarterly cash flow statement line items beyond cash provided by operating activities and capital expenditures
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was checked against the filing text, and a metric whose value, prior period and change do not add up is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
Innospec is a specialty chemicals company listed on NASDAQ. The 8‑K filing provides its first public Q3 2026 numbers.
Ticker impact
Innospec reported Q3 2026 results with revenue up 7% YoY, EPS $1.29 beating prior year and a 9% dividend increase.
likely upward pressure as market prices in stronger earnings and higher dividend.
Revenue growth, double‑digit operating income increase, and a dividend raise are fresh material that can move the stock.
Market effects
Strong performance in performance chemicals and oilfield services may lift peers in specialty chemicals.
Positive for U.S. specialty chemicals sector and dividend‑focused investors.
Modest; primarily affects Innospec and its immediate industry.
Counterpoint
If the market has already priced in the dividend increase, the stock may face limited upside.
Key entities
- CompanyInnospec Inc.
NASDAQ‑listed specialty chemicals producer.
- ExecutivePatrick S. Williams
President and CEO who commented on the results.
